IFNAR1 and viral infectious disease: Here, for the first time we found that apigenin can inhibit the ubiquitination and degradation of IFNAR1, suggesting its potential as a new adjuvant for improving the efficacy of type I IFNs in the treatment of viral infections or cancers.